JPMORGAN CHASE & CO - CONTRAVIR PHARMACEUTICALS IN ownership

CONTRAVIR PHARMACEUTICALS IN's ticker is CTRVXXXX and the CUSIP is 21234W103. A total of 1 filers reported holding CONTRAVIR PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CONTRAVIR PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2018$46,000
-36.1%
200,0000.0%0.00%
Q4 2017$72,000
-31.4%
200,0000.0%0.00%
Q3 2017$105,000
-9.5%
200,0000.0%0.00%
Q2 2017$116,000
-67.2%
200,0000.0%0.00%
Q1 2017$354,000
+47.5%
200,0000.0%0.00%
Q4 2016$240,000200,000
+44443.4%
0.00%
Q3 2016$04490.0%0.00%
Q2 2016$0
-100.0%
4490.0%0.00%
Q4 2015$1,0004490.00%
Other shareholders
CONTRAVIR PHARMACEUTICALS IN shareholders Q2 2018
NameSharesValueWeighting ↓
EAM Investors, LLC 670,593$3,401,0000.45%
Prospera Financial Services Inc 184,100$236,0000.05%
HighTower Advisors, LLC 1,047,731$1,257,0000.01%
TWO SIGMA SECURITIES, LLC 15,142$18,0000.01%
TEACHERS ADVISORS, LLC 298,781$1,820,0000.00%
TIAA CREF INVESTMENT MANAGEMENT LLC 724,455$4,412,0000.00%
Virtu KCG Holdings LLC 90,490$109,0000.00%
FIRST FOUNDATION ADVISORS 10,000$12,0000.00%
Acrospire Investment Management LLC 2,300$3,0000.00%
Balentine LLC 55$00.00%
View complete list of CONTRAVIR PHARMACEUTICALS IN shareholders